PPL
60
-7
CCL
71
4
APD
42
-2
M
14
2
KLAC
56
-3
JNJ
51
-2
DRI
64
4
NEE
52
-2
FAST
46
-2
STI
3
-9
PLD
51
-5
PYPL
45
-2
VZ
45
-2
GE
85
3
CRM
50
-5
EXC
50
-4
BAC
39
-2
GOOGL
53
2
AIG
51
-2
SWK
80
2
PPL
60
-7
CCL
71
4
APD
42
-2
M
14
2
KLAC
56
-3
JNJ
51
-2
DRI
64
4
NEE
52
-2
FAST
46
-2
STI
3
-9
PLD
51
-5
PYPL
45
-2
VZ
45
-2
GE
85
3
CRM
50
-5
EXC
50
-4
BAC
39
-2
GOOGL
53
2
AIG
51
-2
SWK
80
2
Financhill
Back

Cara Therapeutics Quote, Financials, Valuation and Earnings

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
10

CARA
Cara Therapeutics

Last Price:
0.31
Seasonality Move:
-5.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Cara Therapeutics Price Quote

$0.31
+0.02 (+8.39%)
(Updated: September 19, 2024 at 6:55 PM ET)

Cara Therapeutics Key Stats

Sell
10
Cara Therapeutics (CARA) is a Sell
Day range:
$0.27 - $0.30
52-week range:
$0.24 - $1.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.42
P/B ratio:
1.35%
Volume:
506.1K
Avg. volume:
355.7K
1-year change:
-84.79%
Market cap:
$15.7M
Revenue:
$21M
EPS:
$-2.04

How Much Does Cara Therapeutics Make?

Is Cara Therapeutics Growing As A Company?

  • What Is Cara Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.86%
  • What Is Cara Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cara Therapeutics Stock Price Performance

  • Did Cara Therapeutics Stock Go Up Last Month?
    Cara Therapeutics share price went down by -14.58% last month
  • Did CARA's Share Price Rise Over The Last Year?
    CARA share price fell by -84.79% over the past 1 year

What Is Cara Therapeutics 52-Week High & Low?

Cara Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cara Therapeutics?

  • How Much Debt Does Cara Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cara Therapeutics Have?
    Cash and short term investments quarterly total is $56.6M
  • What Is Cara Therapeutics’s Book Value Per Share?
    Book value per share is 0.21

Is Cara Therapeutics Cash Flow Positive?

  • What Is CARA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$79.9M
  • What Is Cara Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $36.3M
  • What Is Cara Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $34.2M

Cara Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CARA return on invested capital is -189.52%
  • What Is Cara Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -103.2%
  • What Is CARA Return On Equity?
    ROE is a measure of profitability and is -189.52%

Cara Therapeutics Earnings Date & Stock Price

Cara Therapeutics Competitors

  • Who Are Cara Therapeutics's Competitors?
    Below is a list of companies who compete with Cara Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Cocrystal Pharma Inc (COCP)
    • Oragenics Inc (OGEN)
    • Seelos Therapeutics Inc (SEEL)
    • Alaunos Therapeutics Inc (TCRT)

Cara Therapeutics Dividend Yield

Cara Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -33%
Revenue: -85.71% -15.56%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 1.52
Upside from Last Price: 432.87%

Major Shareholders

  • How many CARA shares are owned by institutional investors?
    30M CARA shares are owned by institutional investors
  • How many CARA shares are owned by insiders?
    3.1M CARA shares are owned by insiders